Loading

Please wait...

Cystagon

Generic Name: cysteamine (sis TEE a meen)
Brand Name: Cystagon, Procysbi
Physician reviewed Cystagon patient information - includes Cystagon description, dosage and directions.
  • Prescription Settings
  • X
  • Local Pharmacy Pickup available at . Pick up your medication at any of our participating pharmacies.
  • Mail Order Home Delivery available at , the easiest way to receive your medications.
  • Learn more

Cystagon Coupons & Prices

Set your location
for drug prices near you

Enter your zip code

Please wait while the prices are loaded...
Click here to try again.

Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:

Drug Information:
Cystagon works by reducing the amount of cystine (an amino acid) in the body. Cystagon is used to treat nephropathic cystinosis (NEF-roe-PATH-ik SIS-tin-OH-sis), a rare genetic condition that causes a build-up of cystine in the kidneys and other organs. Too much cystine can cause kidney failure or other medical problems. Cystagon is for use in adults and children, but Procysbi should not be given to a child younger than 1 year old. Cystagon may also be used for purposes not listed in this medication guide. Learn more

Pickup / Home Delivery

USARx offers multiple ways to purchase this medication. Choose the Best option for you!

  • Guaranteed Price
    Local Pharmacy Pickup

    Pay this amount and pick up your prescription at ANY Retail pharmacy of your choice! Walgreens, CVS, Walmart, etc.

  • 30-day supply
    90-day supply
    Mail Order Home Delivery

    The easiest way to receive your medications.

Cystagon Side Effects

Note: This document contains side effect information about cysteamine. Some of the dosage forms listed on this page may not apply to the brand name Cystagon.

In Summary

Common side effects of Cystagon include: lethargy, vomiting, and anorexia. Other side effects include: skin rash. See below for a comprehensive list of adverse effects.

For the Consumer

Applies to cysteamine: oral capsule, oral capsule delayed release

Along with its needed effects, cysteamine (the active ingredient contained in Cystagon) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking cysteamine:

More common

  • Diarrhea
  • drowsiness
  • fever
  • loss of appetite
  • nausea
  • skin rash
  • stomach pain
  • vomiting

Less common

  • Confusion
  • dizziness
  • headache
  • mental depression
  • sore throat
  • trembling

Rare

  • Increased thirst
  • seizures
  • unusual tiredness or weakness

Incidence not known

  • Blistering, peeling, or loosening of the skin
  • blurred or double vision
  • bone lesions
  • bulging soft spot on the head of an infant
  • change in the ability to see colors, especially blue or yellow
  • chills
  • continuing ringing or buzzing or other unexplained noise in the ears
  • cough
  • eye pain
  • hearing loss
  • itching
  • joint or muscle pain
  • loss of appetite
  • loss of vision
  • pain behind the eyes
  • pain in the legs
  • pain with eye movement
  • red skin lesions, often with a purple center
  • red, irritated eyes
  • reddish purple lines on the arms, face, legs, trunk, or groin
  • severe headache
  • sores, ulcers, or white spots in the mouth or on the lips

Some side effects of cysteamine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

  • Breath odor
  • constipation
  • hives or welts
  • redness of the skin
  • unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness
  • weight loss

For Healthcare Professionals

Applies to cysteamine: oral capsule, oral delayed release capsule

General

The most common adverse events were vomiting, abdominal pain, nausea, anorexia, fever, diarrhea, lethargy, headache, and rash.

Gastrointestinal

Very common (10% or more): Vomiting (35%), diarrhea (16%)

Common (1% to 10%): Nausea, bad breath, abdominal pain, dyspepsia

Uncommon (0.1% to 1%): Gastrointestinal ulceration and bleeding, constipation, gastroenteritis, duodenitis

Metabolic

Very common (10% or more): Anorexia (31%)

Uncommon (0.1% to 1%): Dehydration

Nervous system

Very common (10% or more): Lethargy (11%)

Common (1% to 10%): Dizziness, headache, encephalopathy

Uncommon (0.1% to 1%): Somnolence, seizures, convulsions, ataxia, confusion, tremor, hyperkinesia, jitteriness

Postmarketing reports: Benign intracranial hypertension with papilledema

Other

Very common (10% or more): Fever (22%)

Common (1% to 10%): Fatigue, asthenia

Uncommon (0.1% to 1%): Decreasing hearing

Dermatologic

Common (1% to 10%): Rash, skin odor

Uncommon (0.1% to 1%): Hair color changes, skin fragility (molluscoid pseudomotor on elbows)

Frequency not reported: Urticaria

Postmarketing reports: Skin lesions, skin striae, skin fragility

Cases of Ehlers-Danlos like syndrome and vascular disorders on elbows have been reported in children chronically treated with high doses of different cysteamine preparations. In cases where histopathological examination of the skin was performed, the results suggested angioendotheliomatosis.

Hepatic

Common (1% to 10%): Abnormal liver function

Frequency not reported: Elevated alkaline phosphatase

Cardiovascular

Uncommon (0.1% to 1%): Hypertension

Genitourinary

Uncommon (0.1% to 1%): Abnormal urine odor

Hematologic

Uncommon (0.1% to 1%): Leukopenia, anemia

Immunologic

Uncommon (0.1% to 1%): Anaphylactic reaction

Musculoskeletal

Uncommon (0.1% to 1%): Joint hyperextension, leg pain, genu valgum, osteopenia, compression fracture, scoliosis

Postmarketing reports: Molluscoid pseudotumors

Psychiatric

Uncommon (0.1% to 1%): Nervousness, abnormal thinking, depression, emotional lability, hallucinations, nightmares

Renal

Uncommon (0.1% to 1%): Nephrotic syndrome, interstitial nephritis, renal failure

Cases of nephrotic syndrome have been reported within 6 months of starting therapy with progressive recovery after treatment discontinuation. In some cases, histology showed a membranous glomerulonephritis of the renal allograft and hypersensitivity interstitial nephritis.

Editorial References and Review

Medically reviewed by USARx EDITORIAL TEAM Last updated on 1/1/2020.

Source: Drugs.com Cystagon (www.drugs.com/mtm/cystagon.html).